Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat Model.

Madka V, Kumar G, Pathuri G, Zhang Y, Lightfoot S, Asch AS, Mohammed A, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2020 Feb;13(2):185-194. doi: 10.1158/1940-6207.CAPR-19-0265. Epub 2019 Nov 7.

PMID:
31699708
2.

Targeting cholecystokinin-2 receptor for pancreatic cancer chemoprevention.

Mohammed A, Janakiram NB, Suen C, Stratton N, Lightfoot S, Singh A, Pathuri G, Ritchie R, Madka V, Rao CV.

Mol Carcinog. 2019 Oct;58(10):1908-1918. doi: 10.1002/mc.23084. Epub 2019 Jul 16.

PMID:
31313401
3.

Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.

Yarla NS, Gali H, Pathuri G, Smriti S, Farooqui M, Panneerselvam J, Kumar G, Madka V, Rao CV.

Semin Cancer Biol. 2019 Jun;56:168-174. doi: 10.1016/j.semcancer.2018.08.011. Epub 2018 Sep 3. Review.

PMID:
30189250
4.

Development of a dietary formulation of the SHetA2 chemoprevention drug for mice.

Benbrook DM, Janakiram NB, Chandra V, Pathuri G, Madka V, Stratton NC, Masamha CP, Farnsworth CN, Garcia-Contreras L, Hatipoglu MK, Lighfoot S, Rao CV.

Invest New Drugs. 2018 Aug;36(4):561-570. doi: 10.1007/s10637-017-0550-0. Epub 2017 Dec 22.

5.

Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer.

Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV.

Oncotarget. 2017 Oct 26;8(58):97822-97834. doi: 10.18632/oncotarget.22085. eCollection 2017 Nov 17.

6.

Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.

Babu A, Amreddy N, Muralidharan R, Pathuri G, Gali H, Chen A, Zhao YD, Munshi A, Ramesh R.

Sci Rep. 2017 Nov 7;7(1):14674. doi: 10.1038/s41598-017-15012-5.

7.

Synthesis and in vivo evaluation of ortho-[(124)I]iodohippurate for PET renography in healthy rats.

Pathuri G, Hedrick AF, Awasthi V, Cowley BD Jr, Gali H.

Appl Radiat Isot. 2016 Sep;115:251-255. doi: 10.1016/j.apradiso.2016.07.002. Epub 2016 Jul 5.

PMID:
27434486
8.

Small-Molecule Inhibition of GCNT3 Disrupts Mucin Biosynthesis and Malignant Cellular Behaviors in Pancreatic Cancer.

Rao CV, Janakiram NB, Madka V, Kumar G, Scott EJ, Pathuri G, Bryant T, Kutche H, Zhang Y, Biddick L, Gali H, Zhao YD, Lightfoot S, Mohammed A.

Cancer Res. 2016 Apr 1;76(7):1965-74. doi: 10.1158/0008-5472.CAN-15-2820. Epub 2016 Feb 15.

9.

Evaluation of [¹⁸F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease.

Pathuri G, Hedrick AF, Awasthi V, Cowley BD Jr, Gali H.

Nucl Med Biol. 2016 Jan;43(1):1-5. doi: 10.1016/j.nucmedbio.2015.10.002. Epub 2015 Oct 22.

PMID:
26702780
10.

Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography.

Pathuri G, Hedrick AF, January SE, Galbraith WK, Awasthi V, Arnold CD, Cowley BD Jr, Gali H.

J Labelled Comp Radiopharm. 2015 Jan;58(1):14-9. doi: 10.1002/jlcr.3255. Epub 2014 Dec 29.

PMID:
25545452
11.

Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.

Pathuri G, Madka V, Hedrick AF, Lightfoot SA, Awasthi V, Cowley BD Jr, Rao CV, Gali H.

Mol Pharm. 2014 Aug 4;11(8):2948-53. doi: 10.1021/mp5002872. Epub 2014 Jul 10.

12.

Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice.

Pathuri G, Li Q, Mohammed A, Gali H, Pento JT, Rao CV.

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1380-2. doi: 10.1016/j.bmcl.2014.01.042. Epub 2014 Jan 27.

13.

Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cells.

Janakiram NB, Mohammed A, Brewer M, Bryant T, Biddick L, Lightfoot S, Pathuri G, Gali H, Rao CV.

Cancer Prev Res (Phila). 2014 Mar;7(3):300-9. doi: 10.1158/1940-6207.CAPR-13-0345. Epub 2014 Jan 15.

14.

Evaluation of 99mTc-probestin for imaging APN expressing tumors by SPECT.

Pathuri G, Hedrick AF, Awasthi V, Ihnat MA, Gali H.

Bioorg Med Chem Lett. 2013 Sep 15;23(18):5049-52. doi: 10.1016/j.bmcl.2013.07.046. Epub 2013 Jul 29.

PMID:
23937983
15.

Solid phase synthesis and biological evaluation of probestin as an angiogenesis inhibitor.

Pathuri G, Thorpe JE, Disch BC, Bailey-Downs LC, Ihnat MA, Gali H.

Bioorg Med Chem Lett. 2013 Jun 15;23(12):3561-4. doi: 10.1016/j.bmcl.2013.04.031. Epub 2013 Apr 23.

PMID:
23664876
16.

Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent.

Pathuri G, Hedrick AF, Awasthi V, Gali H.

Nucl Med Biol. 2012 Nov;39(8):1195-201. doi: 10.1016/j.nucmedbio.2012.07.002. Epub 2012 Aug 13.

PMID:
22898317
17.

Synthesis and biodistribution studies of technetium-99m-labeled aminopeptidase N inhibitor conjugates.

Pathuri G, Hedrick AF, Disch BC, Ihnat MA, Awasthi V, Gali H.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4567-70. doi: 10.1016/j.bmcl.2012.05.106. Epub 2012 Jun 6.

PMID:
22727671
18.

Synthesis and evaluation of novel Tc-99m labeled probestin conjugates for imaging APN/CD13 expression in vivo.

Pathuri G, Hedrick AF, Disch BC, Doan JT, Ihnat MA, Awasthi V, Gali H.

Bioconjug Chem. 2012 Jan 18;23(1):115-24. doi: 10.1021/bc200546b. Epub 2011 Dec 20.

19.

Renogram comparison of p-[(18)F]fluorohippurate with o-[(125)I]iodohippurate and [(99m)Tc]MAG3 in normal rats.

Pathuri G, Sahoo K, Awasthi V, Gali H.

Nucl Med Commun. 2011 Oct;32(10):908-12. doi: 10.1097/MNM.0b013e32834a6db6.

PMID:
21876402
20.

Synthesis and in vivo evaluation of p-18F-Fluorohippurate as a new radiopharmaceutical for assessment of renal function by PET.

Awasthi V, Pathuri G, Agashe HB, Gali H.

J Nucl Med. 2011 Jan;52(1):147-53. doi: 10.2967/jnumed.110.075895. Epub 2010 Dec 13.

21.

Synthesis and in vivo evaluation of Tc-99m-labeled cyclic CisoDGRC peptide conjugates for targeting αvβ3 integrin expression.

Pathuri G, Sahoo K, Awasthi V, Gali H.

Bioorg Med Chem Lett. 2010 Oct 15;20(20):5969-72. doi: 10.1016/j.bmcl.2010.08.082. Epub 2010 Aug 21.

PMID:
20829039
22.

Feasibility Evaluation of Detecting Hydroxymethylphosphine Oxide In Vivo by (31)P-MRS.

Doblas S, Pathuri G, Towner RA, Gali H.

Int J Biomed Sci. 2010 Sep;6(3):228-32.

Supplemental Content

Loading ...
Support Center